You have no items in your shopping cart.
Epratuzumab Antibody
Description
Research Area
Images & Validation
−
Key Properties
−| CAS Number | 205923-57-5 |
|---|---|
| MW | 146.58 kDa |
| Purity | >95% |
| Target | Immunology/Inflammation related,Others |
Bioactivity
−| In Vitro |
|---|
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Anti-CD22 [hL22 (Epratuzumab)] [orb411593]
Blocking, FC, IP
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-CD22 [hL22 (Epratuzumab)] [orb411594]
Blocking, FC, IP
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgSiglec-2 / CD22 Reference Antibody (epratuzumab) [orb1817965]
FC, Kinetics
Human
Monoclonal
Unconjugated
100 μgEpratuzumab Human Monoclonal Antibody [orb2976335]
ELISA, FA, FACS, In vivo
Human
Human
Monoclonal
Unconjugated
100 μg, 1 mgEpratuzumab Human Monoclonal Antibody [orb2978447]
ELISA, FA, FACS, In vivo
Human
Human Humanized
Monoclonal
Unconjugated
100 μg, 1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
Documents Download
Request a Document
Protocol Information
Epratuzumab Antibody (orb1980638)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411593_1.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411593_2.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411593_3.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411594_1.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411594_2.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411594_3.png)


